Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Hypothermic liquid ventilation prevents early hemodynamic dysfunction and cardiovascular mortality after coronary artery occlusion complicated by cardiac arrest in rabbits.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      INSERM U955, équipe 3; Institut Mondor de Recherche Biomédicale (IMRB); Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12); Service d'Anatomie Pathologique; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Laboratoire de Recherche en Imagerie : Méthodes d'imagerie des Échanges transcapillaires (LRI - EA4062); Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM); Service d'Anesthésie Réanimation CHU Necker; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Necker - Enfants Malades AP-HP; Pharmacie-Toxicologie; École nationale vétérinaire d'Alfort (ENVA)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12); Ecologie et Evolution des Microorganismes (EEM); Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM); This st udy was supported by a grant (ABYSS- R12031JJ) from the "Agence Nationale pour la Recher che" (Paris, France). R. Tissier was a recipient of a "Contrat d'Interface INSERM-ENV". R. Tissier and A. Berdeaux are named as inventors on a patent application (13/039415).; ANR-11-TECS-0007,ABYSS,Hypothermie thérapeutique par ventilation liquide totale dans les suites d'un arrêt cardiaque réanimé(2011)
    • بيانات النشر:
      HAL CCSD
      Lippincott, Williams & Wilkins
    • الموضوع:
      2013
    • Collection:
      Inserm: HAL (Institut national de la santé et de la recherche médicale)
    • نبذة مختصرة :
      International audience ; OBJECTIVES: Ultrafast and whole-body cooling can be induced by total liquid ventilation with temperature-controlled perfluorocarbons. Our goal was to determine whether this can afford maximal cardio- and neuroprotections through cooling rapidity when coronary occlusion is complicated by cardiac arrest. DESIGN: Prospective, randomized animal study. SETTING: Academic research laboratory. SUBJECTS: Male New Zealand rabbits. INTERVENTIONS: Chronically instrumented rabbits were submitted to coronary artery occlusion and ventricular fibrillation. After 8 minutes of cardiac arrest, animals were resuscitated and submitted to a normothermic follow-up (control group) or to 3 hours of mild hypothermia induced by total liquid ventilation (total liquid ventilation group) or by combination of cold saline infusion and cold blankets application (saline group). Coronary reperfusion was permitted 40 minutes after the onset of occlusion. After awakening, rabbits were followed up during 7 days. MEASUREMENTS AND MAIN RESULTS: Ten animals were resuscitated in each group. In the control group, all animals secondarily died of cardiac/respiratory failure (8 of 10) or neurological dysfunction (2 of 10). In the saline group, the target temperature of 32°C was achieved within 30-45 minutes after cooling initiation. This slightly reduced infarct size versus control (41% ± 16% vs 54% ± 8% of risk zone, respectively; p < 0.05) but failed to significantly improve cardiac output, neurological recovery, and survival rate (three survivors, six death from cardiac/respiratory failure, and one from neurological dysfunction). Conversely, the 32°C temperature was achieved within 5-10 minutes in the total liquid ventilation group. This led to a dramatic reduction in infarct size (13% ± 4%; p < 0.05 vs other groups) and improvements in cardiac output, neurological recovery, and survival (eight survivors, two deaths from cardiac/respiratory failure). CONCLUSIONS: Achieving hypothermia rapidly is critical to improve the ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/24126441; inserm-00957338; https://inserm.hal.science/inserm-00957338; https://inserm.hal.science/inserm-00957338/document; https://inserm.hal.science/inserm-00957338/file/TLV_-_CCM-Revised_2.pdf; PUBMED: 24126441; PUBMEDCENTRAL: PMC5103037
    • الرقم المعرف:
      10.1097/CCM.0b013e3182a63b5d
    • الدخول الالكتروني :
      https://doi.org/10.1097/CCM.0b013e3182a63b5d
      https://inserm.hal.science/inserm-00957338
      https://inserm.hal.science/inserm-00957338/document
      https://inserm.hal.science/inserm-00957338/file/TLV_-_CCM-Revised_2.pdf
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.8F95491A